Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric pepsin and gastric mucin components constitute the primary biochemical environment of the stomach, balancing digestive efficiency with mucosal integrity (StatPearls, NBK537005). Pepsin is a potent aspartic protease secreted as the zymogen pepsinogen, which becomes active in the acidic environment of the stomach to initiate protein digestion (UniProt, P00790). Gastric mucins, primarily MUC5AC and MUC6, are large glycoproteins that form a viscoelastic gel layer protecting the underlying epithelium from the corrosive effects of acid and pepsin (StatPearls, NBK544242). In pathological states such as gastroesophageal reflux disease (GERD) or peptic ulcers, this balance is disrupted, leading to pepsin-mediated damage of esophageal or gastric tissues (PubMed, 24054674). Therapeutic interventions often focus on neutralizing pepsin activity or reinforcing the mucin barrier using agents like alginates or sucralfate (PubChem, CID 6398). These treatments provide a physical or chemical shield that prevents the degradation of the host's protective mucus layer and promotes healing of the mucosa (PubMed, 11051347).
Formation of a physical barrier (raft) to prevent reflux, inhibition of pepsin proteolytic activity, and coating of the gastric mucosa to enhance protection against acid and enzymatic degradation (PubMed, 11051347; PubChem, CID 6398).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric pepsin and gastric mucin.